Cargando…
Author Correction: Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
Autores principales: | Kiyan, Yulia, Schultalbers, Anna, Chernobrivaia, Ekaterina, Tkachuk, Sergey, Rong, Song, Shushakova, Nelli, Haller, Hermann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575975/ https://www.ncbi.nlm.nih.gov/pubmed/37833407 http://dx.doi.org/10.1038/s41598-023-44504-w |
Ejemplares similares
-
Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate
por: Kiyan, Yulia, et al.
Publicado: (2022) -
Author Correction: Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
por: Kiyan, Yulia, et al.
Publicado: (2021) -
Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
por: Njau, Florence, et al.
Publicado: (2020) -
Correction: Calcium dobesilate reduces VEGF signaling by interfering with heparan sulfate binding site and protects from vascular complications in diabetic mice
por: Njau, Florence, et al.
Publicado: (2020) -
Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling
por: Kiyan, Yulia, et al.
Publicado: (2019)